Leukocytes extravasation in acute homocysteinemic rats

被引:11
作者
Fu, WY
Dudman, NPB
Perry, MA
Wang, XL [1 ]
机构
[1] Univ New S Wales, Prince Henry Hosp, Dept Med, Sydney, NSW, Australia
[2] Univ New S Wales, Prince Wales Hosp, Dept Med, Sydney, NSW, Australia
[3] Univ New S Wales, Ctr Thrombosis & Vasc Biol, Sydney, NSW, Australia
[4] Univ New S Wales, Sch Physiol & Pharmacol, Sydney, NSW, Australia
[5] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA
关键词
endothelial dysfunction; leukocyte activation; animal model for hyperhomocysteinemia;
D O I
10.1016/S0021-9150(01)00643-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Homocysteine may promote atherogenesis and thrombogenesis by enhancing leukocyte endothelium interactions. We explored this hypothesis in an acute hyperhomocysteinemia rat model, which was created by a continuous venous homocysteine infusion (4 ml/h/kg body weight) with 2.5 and 10 mg/ml D,L-homocysteine upto 90 min. Venous homocysteine levels were monitored periodically and varied 65-276 mumol/l, a range observed frequently in homocysteinemic and homocystinuric patients. We measured hemodynamic parameters in mesentery by intravital microscopy in rats infused with homocysteine (N = 5 for each dose) and saline (N = 7). Homocysteine infusion for 90 min did not change the mean carotid arterial blood pressure, velocity of red blood cells and rolling leukocyte flux. However at the dose or 10 mg/ml the venular wall shear rate was reduced to 66-69% of the pre-infusion value (P < 0.05). The leukocyte rolling velocity decreased to 78-82% (P < 0.05). The number of leukocytes adhering to the venular wall increased 2.4-fold (P < 0.05), and the leukocyte extravasation increased 4.7-fold (P < 0.001). Each of these effects was time-dependent and homocysteine dose-dependent. But none were observed in saline infused rats. In conclusion, while homocysteine infusion did not change hemodynamic parameters, it significantly enhanced dose-dependent leukocyte endothelium interactions, which may contribute to homocysteine induced endothelial dysfunction. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 45 条
[1]  
ANDERSSON A, 1995, CLIN CHEM, V41, P361
[2]   LIPID-PEROXIDATION IN HOMOCYSTEINAEMIA [J].
BLOM, HJ ;
ENGELEN, DPE ;
BOERS, GHJ ;
STADHOUDERS, AM ;
SENGERS, RCA ;
DEABREU, R ;
TEPOELEPOTHOFF, MTWB ;
TRIJBELS, JMF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (03) :419-422
[3]   Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients [J].
Bunout, D ;
Garrido, A ;
Suazo, M ;
Kauffman, R ;
Venegas, P ;
de la Maza, P ;
Petermann, M ;
Hirsch, S .
NUTRITION, 2000, 16 (02) :107-110
[4]   Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects [J].
Chambers, JC ;
Obeid, OA ;
Kooner, JS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2922-2927
[5]   Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Obeid, OA ;
Kooner, JS .
CIRCULATION, 1999, 99 (09) :1156-1160
[6]   Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults [J].
Chao, CL ;
Kuo, TL ;
Lee, YT .
CIRCULATION, 2000, 101 (05) :485-490
[7]  
Dardik R, 2000, THROMB HAEMOSTASIS, V83, P338
[8]   Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo [J].
Dudman, NPB ;
Temple, SE ;
Guo, XW ;
Fu, WY ;
Perry, MA .
CIRCULATION RESEARCH, 1999, 84 (04) :409-416
[9]   HUMAN ARTERIAL ENDOTHELIAL-CELL DETACHMENT INVITRO - ITS PROMOTION BY HOMOCYSTEINE AND CYSTEINE [J].
DUDMAN, NPB ;
HICKS, C ;
WANG, J ;
WILCKEN, DEL .
ATHEROSCLEROSIS, 1991, 91 (1-2) :77-83
[10]   CIRCULATING LIPID HYDROPEROXIDE LEVELS IN HUMAN HYPERHOMOCYSTEINEMIA - RELEVANCE TO DEVELOPMENT OF ARTERIOSCLEROSIS [J].
DUDMAN, NPB ;
WILCKEN, DEL ;
STOCKER, R .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (04) :512-516